Experimental treatments with engineered RNA are shown in lab animals to reduce symptoms of preeclampsia, a disorder causing high blood pressure in pregnant women. . . . → Read More: RNA Therapy Helps Reduce Preeclampsia Symptoms
|
|||||
Final results from a clinical trial show a preventive treatment desensitizes children and adolescents with peanut allergies against reaction-causing proteins in peanuts for one year. . . . → Read More: Trial Shows Treatment Prevents Peanut Allergy Reactions 
Plant scientists in the U.K. and Australia are making available to their colleagues experimental techniques that speed-up breeding cycles for more commercial crop varieties. . . . → Read More: Faster Crop Breeding Techniques Made Available to Other Scientists 
Synthetic antibodies derived from survivors of Ebola infections are shown to be quick and simple to develop, and in lab mice to provide long-term protection against against Ebola viruses. . . . → Read More: DNA-Encoded Synthetic Antibodies Protect Against Ebola 
Two biotechnology companies developing engineered viruses as cancer therapies plan to create personalized treatments for solid tumors with viruses that harness the immune system. . . . → Read More: Biotechs to Develop Personal Cancer-Killing Virus Vaccines 
A company spun-off from a university biochemistry lab is raising $30 million to fund discovery of treatments targeting RNA, genetic material instructing protein production in cells. . . . → Read More: RNA Therapeutics Company Raises $30M in First Venture Round 
Proteins known to regulate immune cells, given as nanoscale particles, are shown in lab mice to encourage long-term acceptance of a transplanted heart. . . . → Read More: Nanotech Immunotherapy Reduces Heart Transplant Rejection 
Researchers in chemistry at two institutions report new techniques that lab tests show modify current antibiotics to make them more effective against infections that resist today’s antibiotics. . . . → Read More: New Processes Devised to Boost Antibiotics  One comment - (Comments are closed)  New products  biomedical, biotechnology, chemistry, health care, life sciences, pharmaceuticals, physical sciences, university 
A 5 year-old enterprise developing synthetic DNA for medical and agricultural chemicals, as well as data storage, is raising $70 million in its initial public stock offering. . . . → Read More: Synthetic DNA Company Raising $70 Million in IPO Comments are closed Finance biomedical, biotechnology, computer science, engineering, equity, genomics, investment, IPO, life sciences, semiconductors 
The Food and Drug Administration intends to issue new regulatory guidance to cover advances in biotechnology, including genome editing, in animals and plants. . . . → Read More: FDA Preparing Animal, Plant Biotech Regulatory Guidance 2 comments - (Comments are closed) Regulations agriculture, biotechnology, FDA, genomics, life sciences, pharmaceuticals |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
